Diagnostics News and Research

RSS

InDex Pharmaceuticals granted U.S. patent for novel treatment of steroid-resistant inflammation

InDex Pharmaceuticals today announced that it has been granted a patent by the United States Patent and Trademark Office. The patent provides additional protection for the use of Kappaproct® and additional DNA-based immunomodulatory sequences (DIMS) for the treatment of steroid-resistant inflammatory diseases including inflammatory bowel disease, rheumatoid arthritis, psoriasis, asthma, emphysema and chronic obstructive pulmonary disease.

26 Apr 2012

PLUS Diagnostics, MDxHealth partner to co-promote ConfirmMDx for Prostate Cancer

MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, and PLUS Diagnostics today announced that they have entered into an agreement to co-promote MDxHealth's ConfirmMDx for Prostate Cancer test in the United States.

26 Apr 2012

NYU Langone expands MS Comprehensive Care Center

NYU Langone's Multiple Sclerosis (MS) Comprehensive Care Center recently opened the doors to a new clinical practice - the first to occupy NYU Langone Medical Center's new, nearly 300,000-square-foot Ambulatory Care Center located at 240 East 38th Street at Second Avenue in Manhattan.

26 Apr 2012

Lophius Biosciences completes prospective multicenter clinical validation study for T-Track CMV/EBV tests

Lophius Biosciences, a leading developer of novel T-cell based diagnostic testing systems, today announces the successful completion of a prospective multicenter clinical validation study for its T-Track CMV/EBV tests.

25 Apr 2012

Thermo Fisher Scientific first quarter revenues increase 14% to record $3.10 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended March 31, 2012.

From Thermo Fisher Scientific Inc. 25 Apr 2012

Aggredyne closes $3 million Series A convertible preferred stock financing

Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.

23 Apr 2012

DSG's eCaseLink EDC chosen for Ariosa's Non-Invasive Chromosomal Examination of Trisomy study

Ariosa Diagnostics, a molecular diagnostics company focused on prenatal testing, has chosen to use DSG's eCaseLink EDC (electronic data capture) system for the NEXT (Non-Invasive Chromosomal Examination of Trisomy) study.

23 Apr 2012

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

23 Apr 2012

Fun ways for women to get active with 100,000 Acts of Play Challenge

A new survey from the American Cancer Society finds women are 10 percent less likely than men to make time for physical activities they enjoy and that 40 percent of women said they would be more physically active in their free time if it felt less like work and more like play. As a result, the American Cancer Society Choose You movement is calling on women to help close this gap and to discover fun ways to get active with its 100,000 Acts of Play Challenge.

23 Apr 2012

Health Discovery launches MelApp for melanoma risk assessment

Health Discovery Corporation, the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment is featured in this month's Men's Health Magazine.

21 Apr 2012

VeriStrat test may be useful for NSCLC clinical decision-making

Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.

21 Apr 2012

FDA clears Abbott’s iFS Femtosecond laser for use in cataract surgery

Abbott announced today U.S. Food and Drug Administration clearance to use its iFS Advanced Femtosecond Laser to create bow-shaped or curved arcuate incisions in corneal surgery, including cataract surgery.

21 Apr 2012

Scientists discover tumor-targeting neural stem cells

Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target tumor cells outside the central nervous system. This finding, which was demonstrated successfully on breast cancer cells, was recently published in leading peer reviewed journal, Stem Cells.

21 Apr 2012

GE Healthcare, NXT2B partner to develop micro-scale radiotracer infrastructure

GE Healthcare, a unit of General Electric Company, and NXT2B, a privately owned venture capital company, today announced they have entered into a joint financing agreement with the goal of developing a micro-scale radiotracer infrastructure including cyclotron and PET tracer production.

20 Apr 2012

Developments in mesothelioma treatment presented at 3rd European Lung Cancer Conference

New results presented at 3rd European Lung Cancer Conference in Geneva, Switzerland show important steps being made to improve the diagnosis and treatment of malignant pleural mesothelioma, an aggressive cancer of the outer lining of the lungs caused by asbestos exposure.

19 Apr 2012

Merkin Family Foundation pledges new commitment to the Broad Institute

The Merkin Family Foundation today announced a commitment to the Broad Institute of Harvard and MIT to establish the Merkin Institute Fellows, a program that will support some of the most promising and ambitious scientists pursuing bold research at the Broad Institute.

19 Apr 2012

New techniques show promise in detecting early-stage lung cancer

New techniques for identifying lung cancer earlier -including a new type of chest screening, a nanotech 'nose' and a method to examine the cells of the cheek-- are showing substantial promise, according to presentations at the 3rd European Lung Cancer Conference (ELCC) in Geneva.

19 Apr 2012

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

Abbott announced today the results from a Phase 3 trial evaluating the company's investigational compound for advanced Parkinson's disease, levodopa-carbidopa intestinal gel (LCIG).

18 Apr 2012

Bruker introduces new products at Analytica 2012

At Analytica 2012, Bruker today announced several new product introductions for the research, industrial and applied markets, designed to deliver confident analyses with increased sensitivity, specificity and productivity, and to push the boundaries of advanced molecular and materials research applications.

18 Apr 2012

Innovation in healthcare without borders: An invaluable contribution of diagnostics

For the third year in a row, the European Diagnostic Manufacturers Association (EDMA) has been one of the strategic partners of the European Commission in organising the Innovation in Healthcare without Borders conference.

17 Apr 2012

Diagnostics News and Research

InDex Pharmaceuticals granted U.S. patent for novel treatment of steroid-resistant inflammation

PLUS Diagnostics, MDxHealth partner to co-promote ConfirmMDx for Prostate Cancer

NYU Langone expands MS Comprehensive Care Center

Lophius Biosciences completes prospective multicenter clinical validation study for T-Track CMV/EBV tests

Thermo Fisher Scientific first quarter revenues increase 14% to record $3.10 billion

Aggredyne closes $3 million Series A convertible preferred stock financing

DSG's eCaseLink EDC chosen for Ariosa's Non-Invasive Chromosomal Examination of Trisomy study

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Fun ways for women to get active with 100,000 Acts of Play Challenge

Health Discovery launches MelApp for melanoma risk assessment

VeriStrat test may be useful for NSCLC clinical decision-making

FDA clears Abbott’s iFS Femtosecond laser for use in cataract surgery

Scientists discover tumor-targeting neural stem cells

GE Healthcare, NXT2B partner to develop micro-scale radiotracer infrastructure

Developments in mesothelioma treatment presented at 3rd European Lung Cancer Conference

Merkin Family Foundation pledges new commitment to the Broad Institute

New techniques show promise in detecting early-stage lung cancer

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

Bruker introduces new products at Analytica 2012

Innovation in healthcare without borders: An invaluable contribution of diagnostics

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News